Company name: ZenPharm
Description: Provider of refined cannabis products to the EU pharmaceutical market. The company offers delivery of cannabis-based medical treatments.
Year founded: 2019
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was formed as a joint venture between Zenabis Global and Natrix Sciences Limited Malta on October 02, 2019. This milestone enables Zenabis to supply the European market with bulk dried medicinal cannabis flower.
Number of active investors:
Profile last updated: 21-May-2020
Last known valuation:
Last known valuation date: